Your cart is currently empty!
BPC-157 + TB-500 : WOLVERINE 20
BPC-157 + TB-500 : WOLVERINE BPC-157 + TB-500 blend is a research peptide combination consisting of the synthetic pentadecapeptide BPC-157 (derived from a gastric protective protein) and TB-500 (a synthetic fragment of thymosin beta-4). Preclinical studies suggest that BPC-157 promotes angiogenesis and tendon-to-bone healing, while TB-500 facilitates actin regulation, cell migration, and tissue remodeling. When…
26 in stock
BPC-157 + TB-500 : WOLVERINE
BPC-157 + TB-500 blend is a research peptide combination consisting of the synthetic pentadecapeptide BPC-157 (derived from a gastric protective protein) and TB-500 (a synthetic fragment of thymosin beta-4). Preclinical studies suggest that BPC-157 promotes angiogenesis and tendon-to-bone healing, while TB-500 facilitates actin regulation, cell migration, and tissue remodeling. When studied together, these peptides may exhibit complementary actions supporting accelerated tissue repair in various injury models.[1][2]
Key Research Areas
- Soft Tissue & Musculoskeletal Repair – In rat models of Achilles tendon transection and muscle crush injury, BPC-157 has been shown to accelerate functional recovery, enhance collagen organization, and promote tendon healing; TB-500 supports cell migration and actin sequestration in preclinical wound models.[3][4]
- Angiogenesis & Vascularization – BPC-157 upregulates VEGF signaling and endothelial function in ischemic models, while TB-500 promotes endothelial differentiation and new vessel formation in dermal and cardiac tissues.[5][6]
- Inflammation & Regeneration Pathways – Preclinical investigations indicate the combination may modulate inflammatory mediators, enhance fibroblast activity, and support extracellular matrix remodeling through complementary mechanisms.[1][7]
Product Specifications
| CAS Number | BPC-157: 137525-51-0 / TB-500: 77591-33-4 |
| Molecular Formula | Blend (BPC-157: C62H98N16O22 / TB-500: C212H350N56O78S) |
| Molar Mass | Blend (BPC-157: 1419.56 g/mol / TB-500: 4963.50 g/mol) |
| Sequence | BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
TB-500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser |
| Synonyms | BPC-157/TB-500 Blend, Regeneration Blend, Wolverine Blend |
| Purity | ≥99% (HPLC) |
| Form | Lyophilized powder |
| Storage | −20°C (long-term), 2–8°C (reconstituted) |
| Solubility | Bacteriostatic water or saline for reconstitution |
References
- 1. Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011. PubMed
- 2. Sosne G, et al. Thymosin beta 4: potential to treat corneal and dermal wounds. Ann N Y Acad Sci. 2010. PubMed
- 3. Staresinic M, et al. Effective therapy of transected quadriceps muscle in rat: gastric pentadecapeptide BPC 157. J Orthop Res. 2006. PubMed
- 4. Philp D, et al. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev. 2004. PubMed
- 5. Seiwerth S, et al. BPC 157 and blood vessels. Curr Pharm Des. 2014. PubMed
- 6. Smart N, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 2007. PubMed
- 7. Sikiric P, et al. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease. Curr Pharm Des. 2013. PubMed





